Similar articles for PMID: 16845325

Year	Number of Results
1942	1
1966	1
1968	1
1992	3
1993	2
1994	1
1995	1
1997	6
1998	4
1999	4
2000	4
2001	5
2002	5
2003	17
2004	10
2005	30
2006	31
2007	18
2008	15
2009	13
2010	9
2011	6
2012	9
2013	7
2014	6
2015	4
2016	2
2017	1
2018	2
2019	5
2020	4
2021	3
2022	2
2023	3
2024	0

1

Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.

Bloethner S, Hemminki K, Thirumaran RK, Chen B, Mueller-Berghaus J, Ugurel S, Schadendorf D, Kumar R. Bloethner S, et al. Melanoma Res. 2006 Aug;16(4):297-307. doi: 10.1097/01.cmr.0000222597.50309.05. Melanoma Res. 2006. PMID: 16845325

2

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.

Bloethner S, Chen B, Hemminki K, Müller-Berghaus J, Ugurel S, Schadendorf D, Kumar R. Bloethner S, et al. Carcinogenesis. 2005 Jul;26(7):1224-32. doi: 10.1093/carcin/bgi066. Epub 2005 Mar 10. Carcinogenesis. 2005. PMID: 15760917

3

CDKN2A/p16 is inactivated in most melanoma cell lines.

Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK. Castellano M, et al. Cancer Res. 1997 Nov 1;57(21):4868-75. Cancer Res. 1997. PMID: 9354451

4

Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.

Pollock PM, Welch J, Hayward NK. Pollock PM, et al. Cancer Res. 2001 Feb 1;61(3):1154-61. Cancer Res. 2001. PMID: 11221846

5

Codeletion of the JUN proto-oncogene and the CDKN2A tumor-suppressor gene in HRAS-transformed rat embryo fibroblast cell lines.

Zhou JN, Ljungdahl S, Röhme D, Levan G, Shoshan MC, Linder S. Zhou JN, et al. Genes Chromosomes Cancer. 1997 Sep;20(1):82-9. Genes Chromosomes Cancer. 1997. PMID: 9290958

6

Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.

Pollock PM, Yu F, Qiu L, Parsons PG, Hayward NK. Pollock PM, et al. Oncogene. 1995 Aug 17;11(4):663-8. Oncogene. 1995. PMID: 7651729

7

Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.

Berggren P, Kumar R, Sakano S, Hemminki L, Wada T, Steineck G, Adolfsson J, Larsson P, Norming U, Wijkström H, Hemminki K. Berggren P, et al. Clin Cancer Res. 2003 Jan;9(1):235-42. Clin Cancer Res. 2003. PMID: 12538475

8

Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines.

Raschke S, Balz V, Efferth T, Schulz WA, Florl AR. Raschke S, et al. Genes Chromosomes Cancer. 2005 Jan;42(1):58-67. doi: 10.1002/gcc.20119. Genes Chromosomes Cancer. 2005. PMID: 15495191

9

Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.

Jamieson S, Alexiadis M, Fuller PJ. Jamieson S, et al. Gynecol Oncol. 2004 Dec;95(3):603-9. doi: 10.1016/j.ygyno.2004.07.062. Gynecol Oncol. 2004. PMID: 15581971

10

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.

Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS. Thompson PM, et al. Cancer Res. 2001 Jan 15;61(2):679-86. Cancer Res. 2001. PMID: 11212268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

219 results

Results by year